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Adherence of pathogens to extracellular matrix pro-
teins and host cells is one of the essential steps in the 
microbial colonization of the human organism. The ad-
hesion of C. glabrata, i.e. the second major causative 
agent of human disseminated candidiases after C. al-
bicans, to the host epithelium mainly engages specific 
fungal cell wall proteins – epithelial adhesins (Epa) – in 
particular, Epa1, Epa6 and Epa7. The aim of the present 
study was to identify the major Epa protein involved 
in the interactions with the human extracellular matrix 
protein – fibronectin – and to present the kinetic and 
thermodynamic characteristics of these interactions. A 
relatively novel gel-free approach, i.e. the “cell surface 
shaving” that consists in short treatment of fungal cells 
with trypsin was employed to identify the C. glabrata 
surfaceome. Epa6 was purified, and the isolated pro-
tein was characterized in terms of its affinity to human 
fibronectin using a microplate ligand-binding assay and 
surface plasmon resonance measurements. The disso-
ciation constants for the binding of Epa6 to fibronectin 
were determined to range between 9.03 × 10–9 M and 
7.22 × 10–8 M, depending on the method used (surface 
plasmon resonance measurements versus the microplate 
ligand-binding assay, respectively). The identified fungal 
pathogen-human host protein-protein interactions might 
become a potential target for novel anticandidal thera-
peutic approaches.
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INTRODUCTION
In clinical practice, a continuously increasing inci-
dence of severe fungal diseases has been recorded over 
the last few decades, which has now become a serious 
medical problem. Candida albicans is still diagnosed as one 
of the major fungal pathogens of humans; however, the 
frequency of severe candidiases caused by other Candida 
species has alarmingly increased (Tadec et al., 2016). Cur-
rently, C. glabrata is considered to be the second major 
causative agent of fungal diseases after C. albicans, re-
sponsible for almost 22% of superficial and systemic 
candidal infections in North America and for 10% of 
candidiases in Europe (Perlroth et al., 2007; Bassetti et 
al., 2015; Gupta et al., 2015). Interestingly, C. glabrata is 
more closely related to baker’s yeast Saccharomyces cerevi-
siae than to other Candida species (Dujon et al., 2004). In 
contrast to C. albicans, C. glabrata is strictly haploid and 
normally grows only in the yeast-like form (Kaur et al., 
2005), although it still possesses mechanisms appropriate 
both for a commensal lifestyle within the human organ-
ism and for the host infection.
One of the critical steps in the infectious process, es-
sential both for the initial stages of host colonization 
and for further development of disease, is the adherence 
of the pathogen to the host epithelial cells. Thus, many 
bacterial species possess complex systems, mainly local-
ized on the cell surface, involved in detection of host li-
gands for further induction of the expression of specific 
bacterial adhesins, which allow the pathogen to attach 
firmly to host tissues (Kline et al., 2009). As in bacteria, 
the cell surface of Candida spp. is involved in adhesion 
of these fungi to host cells and proteins during infec-
tion. Among all cell wall components, proteins exposed 
on the cell surface are considered to play a key role in 
candidal pathogenicity (Chaffin et al., 2008; Heilmann et 
al., 2012). Accordingly, the interactions between proteins 
exposed at C. glabrata cell surface and human epithelial 
cells were characterized and shown mainly to engage 
Epa1, Epa6 and Epa7 (Castano et al., 2005), i.e. proteins 
belonging to the epithelial adhesin (Epa) family (Kaur et 
al., 2005; Roetzer et al., 2011). Moreover, Epa6 and Epa7 
were found to contribute to strong hydrophobic inter-
actions with various abiotic surfaces and to participate 
in biofilm formation on the surface of medical devices 
such as vascular and urinary catheters, artificial joints, 
stents, or implants (El-Kirat-Chatel et al., 2015; d’Enfert 
& Janbon, 2016). Epa1 and Epa7 were shown to be in-
volved in interactions with endothelial cells (Zupancic et 
al., 2008), whereas Epa1 could also mediate adherence 
to macrophages and mononuclear cells from peripheral 
blood (Kuhn & Vyas, 2012).
One of the most important proteinaceous compo-
nents of the extracellular matrix (ECM) is fibronectin 
(FN), which is a multifunctional protein involved in 
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clotting, wound repair, and host cell adhesion and mi-
gration (Tate et al., 2002; Ghost et al., 2006). Binding 
of this high-molecular-mass glycoprotein on the fungal 
cell surface can greatly enhance the virulence of Candida 
species, because adsorption thereof provides a bridge to 
deeper tissues, thereby facilitating colonization and dis-
semination of pathogens within the human organism 
(Sturtevand & Calderone, 1997; Nett et al., 2016). Cer-
tain proteins exposed on the surface of C. albicans cells, 
such as a typical adhesin Als1 (agglutinin-like sequence), 
are known to interact with FN (Donohue et al., 2011; 
Jordan et al., 2014). Moreover, some of the cell wall-
associated proteins of non-albicans Candida species, such 
as C. tropicalis and C. parapsilosis, play an important role 
in adherence to ECM proteins (Kozik et al., 2015). For 
C. glabrata, the binding of N-terminal part of Epa1 to 
FN was only demonstrated after overexpression of this 
fragmental fungal protein in Escherichia coli and its purifi-
cation (Ielais et al., 2014).
Since the phenomenon of fungal adhesion is based on 
interactions of candidal surface-exposed proteins with 
cells and soluble proteins of the host, in order to effec-
tively prevent such infections, it is necessary to recog-
nize in details the structure of the pathogen’s cell wall 
and to understand the mechanisms of adhesion (Brunke 
& Hube, 2013). In the present study, we analyzed the 
C. glabrata surfaceome and identified Epa6 as one of the 
major factors capable of binding to human FN. Further-
more, the interaction of FN with isolated and purified 
Epa6 was characterized in terms of kinetic and thermo-
dynamic parameters.
MATERIALS AND METHODS
Yeast strain and culturing conditions. C. glabrata 
strain CBS138 (ATCC® 2001TM) was purchased from the 
American Type Culture Collection (Manassas, VA, USA). 
Yeast cells were grown in YPD medium, pH 6.0 (1% 
yeast extract, 2% soybean peptone and 2% glucose) (Sig-
ma, St. Louis, MO, USA) at 37°C for 17 h. To induce 
Epa6 surface exposition, the cells were cultured in the 
defined medium RPMI 1640, pH 7.4 (PAA Laborato-
ries GmbH, Pasching, Austria) at 37°C for 72 h. In this 
particular case, human FN (R&D Systems, Minneapolis, 
MN, USA) was added to the YPD medium to a final 
concentration of 0.2 mg/ml.
Experimental strategy. We used four sets of experi-
ments aimed to identify major FN-binding proteins of 
C. glabrata cell wall that finally allowed to assign this ac-
tivity to Epa6 protein:
(i) the extraction of cell wall-associated proteins with 
β-1,6-glucanase from C. glabrata cells cultured in YPD 
and RPMI media and the analysis of these extracts for 
FN binding;
(ii) Epa6 purification, using a protocol including: ion 
exchange chromatography, selection of fractions with 
FN-binding activity, gel filtration;
(iii) kinetic and thermodynamic characterization of the 
interactions between purified Epa6 and FN, using a mi-
croplate ligand-binding assay and SPR measurements;
(iv) tryptic “shaving” of C. glabrata cells cultured in 
the presence of FN, followed by the identification of cell 
surface-exposed proteins.
Extraction of cell wall-associated proteins. The cell 
wall-associated proteins were extracted from both bioti-
nylated and non-biotinylated cells, using the previously 
published protocols (Kozik et al., 2015). Briefly, to bioti-
nylate the proteins associated with the fungal cell wall, 
1 g (wet weight) of the C. glabrata cells (YPD-cultured at 
37°C for 17 h or RPMI 1640-cultured at 37°C for 72 h) 
was suspended in 0.1 M bicarbonate buffer, pH 8.3 and 
a solution of N-hydroxysuccinimide-biotin (NHS-biotin, 
Sigma) in dimethylformamide (1 mg/50 μl) was added, 
followed by sample incubation for 1 h at room tempera-
ture in the dark. After incubation, the cells were exten-
sively washed with 50 mM phosphate buffer (pH 6.0) 
in order to remove the excess reagent. Next, the fungal 
cells were placed in 1 ml of McIlvaine buffer (a mixture 
of 0.1 M citric acid and 0.2 M disodium phosphate, pH 
6.0, with 0.5 M sodium tartrate as an osmotic stabiliz-
er) and treated with 2 U of β-1,6-glucanase for 24 h at 
37°C. After extraction, the supernatants were collected 
and dialyzed against phosphate buffered saline (PBS), 
pH 7.4, at 4°C for 48 h. Cell membrane integrity was 
tested by staining with Trypan Blue (Sigma). The protein 
mixtures obtained were characterized by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
in the Laemmli system (Laemmli, 1970).
Analysis of binding of biotinylated cell wall-asso-
ciated proteins to microplate-immobilized FN. FN 
was immobilized in the wells of the MaxiSorp 96-well 
microplate (Sarstedt, Nümbrecht, Germany) by overnight 
incubation at 4°C (5 pmol of protein per well). The un-
occupied surface in each well was blocked with 3% BSA 
in PBS at 4°C overnight. Solutions of biotinylated fun-
gal protein in PBS with 10 mM calcium chloride (50 μl) 
were added to the wells and then the microplate was in-
cubated at 37°C for 1.5 h. The amounts of bound bioti-
nylated proteins were determined with the use of a SA-
HRP/TMB detection system (Rapala-Kozik et al., 2008).
Purification of Epa6. Ion-exchange chromatography. 
The mixture of the extracted cell wall-associated proteins 
was dialyzed against 20 mM Tris-HCl buffer for 48 h 
and then applied to a Resource Q column (6.4 mm × 30 
mm, particle size 15 μm) (Pharmacia Biotech, Uppsala, 
Sweden). The proteins were eluted using a 20 ml lin-
ear gradient of 0–0.5 M NaCl at a flow rate of 1 ml/
min. Fractions (1 min) were collected and analyzed for: 
(i) SDS-PAGE characteristics; (ii) FN-binding activity, 
and (iii) the presence of Epa proteins (identified by mass 
spectrometry).
Competitive FN-binding assay of fractions obtained 
from ion-exchange chromatography. Fractions eluted 
from the Resource Q column were analyzed for a com-
petition with biotinylated cell wall proteins for binding 
to the microplate-adsorbed FN. For this assay, FN was 
immobilized in the wells of the MaxiSorp 96-well micro-
plate (Sarsted) by overnight incubation at 4°C (5 pmol 
protein per well). After this and all following steps, the 
wells were washed three times with 1% BSA in PBS 
buffer. The unoccupied surface in each well was blocked 
with 3% BSA in PBS at 4°C by overnight incubation. 
The mixture of biotinylated cell wall-extracted proteins 
at a concentration of 20 μg/ml (25 μl) with a given 
fraction from Resource Q chromatography (25 μl) was 
added to the wells and the plate was incubated at 37°C 
for 1.5 h. The wells with biotinylated cell wall-extracted 
proteins, diluted two-fold with PBS (50 μl), represent-
ed the maximal binding (taken as 100%). The amounts 
of bound proteins were determined with the use of the 
SA-HRP/TMB detection system. The wells without FN, 
which were surface-blocked with 3% BSA, served as a 
control. The values obtained for the control samples 
were subtracted from the total binding.
Selection of Epa6-containing fractions. To identify the 
content of protein bands on SDS-PAGE gels, the bands 
were manually excised and destained in 25% acetonitrile 
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(ACN) and then in 50% ACN in 25 mM NH4HCO3. 
The next step was reduction with 50 mM DTT in 25 
mM NH4HCO3 at 37°C for 45 min, followed by alkyla-
tion with 55 mM iodoacetamide in 25 mM NH4HCO3 
for 90 min at room temperature in the dark. The excess 
reagents were washed out with 50% ACN. The gel piec-
es were then dehydrated in 100% ACN and dissolved 
in 13 μl of a trypsin (Promega, Madison, WI, USA) 
solution (0.2 μg/μl in 25 mM NH4HCO3), followed by 
the incubation of the sample for 15 min at room tem-
perature. After addition of 20 μl of 25 mM NH4HCO3, 
the digestion was continued at 37°C overnight. Peptides 
were extracted by sonication in 50% ACN and 0.5% for-
mic acid at 37°C. The peptides obtained were separated 
and analyzed by liquid chromatography-coupled tandem 
mass spectrometry (LC-MS/MS), following protocols de-
scribed previously (Karkowska-Kuleta et al., 2015).
Gel filtration. After separation on the Resource Q 
column, Epa6-containing fractions were injected onto 
a TSK G 3000 SW column (21.5 mm × 30 cm, particle 
size 13 μm) (Tosoh Bioscience, USA). The column was 
eluted with 0.1 M sodium sulfate and 0.1 M sodium di-
hydrogen phosphate, pH 6.7. Proteins were separated at 
a flow rate of 2 ml/min. Fractions were collected, char-
acterized by SDS-PAGE and analyzed by LC-MS/MS.
Labeling of Epa6 with fluorescein. A solution (1 
mg/100 μl) of NHS-fluorescein (Thermo Fisher Scientif-
ic, Waltham, MA, USA) in dimethyl sulfoxide was added 
to purified Epa6 (100 μg) in 200 μl of 0.1 M bicarbonate 
buffer, pH 8.3, and the mixture was incubated at 4°C 
for 4 h, followed by dialysis against PBS at 4°C for 48 h.
Binding of fluorescein-labeled Epa6 to micro-
plate-immobilized FN. For this version of the FN-
binding test, FN was immobilized in the wells of the 
MaxiSorp 96-well microplate (Sarsted) by overnight incu-
bation at 4°C (3 pmol protein per well). The unoccupied 
surface in each well was blocked with 0.5% BSA in PBS 
at 37°C for 3 h. Solutions (50 μl) of fluorescein-labeled 
proteins at increasing concentrations in PBS with 10 mM 
calcium chloride were added to the wells and the plate 
was incubated at 37°C for 1.5 h. The amounts of bound 
proteins were determined with the use of a fluoromet-
ric microplate reader model Synergy H1 (BioTek, Win-
ooski, VT, USA). The wells with immobilized FN and 
filled with solutions containing fluorescein-labeled Epa6 
(at the given concentration) and ten-fold molar excess 
of unlabeled Epa6 served as controls for “ non-specific” 
binding. The signals for non-specific binding were sub-
tracted from the total binding signals. A one-site binding 
model was fitted to the experimental data with the use 
of GraphPad Prism software.
Quantitative surface plasmon resonance (SPR) 
analysis of Epa6 binding to FN. FN was immobi-
lized on CM5 chips of the BIACORE 3000 system (GE 
Healthcare, Uppsala, Sweden) in 10 mM sodium acetate 
buffer, pH 4.5. The immobilization was performed at 
25°C with a flow rate of 10 μl/min for 7 min using an 
Amine Coupling Kit (GE Healthcare), i.e. the mixture 
of 50 mM 1-ethyl-3-(3-dimethylaminopropyl)carbodiim-
ide (EDC) and 200 mM N-hydroxysuccinimide (NHS). 
The remaining activated ester groups were blocked with 
ethanolamine. The immobilization level reached ca. 280 
resonance units (RU). The Epa6 solution was pre-di-
alyzed against a running buffer (10 mM HEPES, 150 
mM sodium chloride, 10 mM calcium chloride, 0.005%, 
w/v, surfactant P20, pH 7.4) and then injected (a con-
centration range of 5–125 nM) through the chip flow 
cells with immobilized FN (and a control cell without 
FN) at a flow rate of 30 μl/min. The association and 
dissociation time was 120 s. The chip surface was regen-
erated between binding cycles by injection of 1 M NaCl 
for 30 seconds. The binding parameters were obtained 
by the analysis of sensograms using BIAevaluation 4.1 
software (GE Healthcare). The dissociation and associa-
tion rate constants (kd and ka) were obtained on the basis 
of a global fit with a simple Langmuir model (1:1) with a 
drifting baseline, and the KD values were calculated as the 
ratios of the rate constants.
Cell surface shaving with trypsin. Protocols de-
scribed previously (Karkowska-Kuleta et al., 2015) were 
used in the analysis. Briefly, after culturing C. glabrata 
yeast in YPD medium, 2 × 107 cells were washed with 
25 mM ammonium bicarbonate buffer (NH4HCO3), 
suspended in 100 μl of the same buffer with 5 mM 
dithiothreitol (DTT), and treated with sequencing-grade 
trypsin (10 μg) (Promega, Madison, WI, USA) at 37°C 
for 5 min. After centrifugation (5 minutes, 6 000 rpm) 
and filtration through a filter with 0.22 μm-diameter 
pores, the supernatant was subjected to further incuba-
tion with trypsin for 5 h at the same temperature. To 
stop the enzymatic reaction, trifluoroacetic acid (TFA) 
(Sigma) was added to the supernatant (final concentra-
tion of 0.1%). After incubation on ice for 15 min, the 
sample was centrifuged (15 min, 12 000 rpm), dried in 
a Speed-Vac (Martin Christ, Osterode am Harz, Germa-
ny) and frozen until further use. The cells that remained 
in the pellet were tested for cell membrane integrity by 
Trypan Blue (Sigma) staining.
Protein identification with LC-MS/MS. The pep-
tides were analyzed with a HCTUltra ETDII ion-trap 
mass spectrometer equipped with an electrospray ioniza-
tion ion source (Bruker, Bremen, Germany) and coupled 
to an ultra-high-performance liquid chromatograph Di-
onex Ultimate 3000 system (Thermo Scientific, Waltham, 
MA, USA). Protocols described previously (Karkowska-
Kuleta et al., 2015) were used in the analysis. Briefly, af-
ter dissolution in 100 μl loading buffer (10% ACN with 
0.1% formic acid), all peptide samples were separated 
on an Accucore C18 column (100 mm × 2.1 mm, par-
ticle size 2.6 μm) (Thermo Fisher Scientific) with a 60 
min gradient (from 10 to 60% of phase B) at a flow-
rate of 0.2 μl/min. Mascot Generic format (.mgf) files 
were generated by Data Analysis 4.0 software (Bruker). 
The lists of the peaks obtained were searched against the 
NCBI protein database with taxonomy restriction to the 
Fungi or SwissProt protein database with taxonomy re-
striction to Homo sapiens, using an in-house Mascot serv-
er (v.2.3.0; Matrix Science, London, UK). The following 
search parameters were applied: enzyme specificity – 
trypsin; permitted number of missed cleavages – 2; fixed 
modification – carbamidomethylation (C); variable mod-
ifications – oxidation (M); protein mass – unrestricted; 
peptide mass tolerance of ± 0.3 Da and fragment mass 
tolerance of ± 0.5 Da.
RESULTS
Binding of immobilized FN by C. glabrata cell wall-
extracted proteins
After culturing the yeast cells in the YPD or RPMI 
1640 media, C. glabrata cell wall proteome was revealed 
and found to differ to some extent depending on growth 
conditions. For instance, after “cell surface shaving”, the 
typical adhesin Epa6 was found only on the cell sur-
face after growth in the RPMI 1640 medium (data not 
shown). A mixture of cell wall-associated proteins, used 
in further studies was obtained after releasing proteins 
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from the cell wall with β-1,6-glucanase. After this treat-
ment, more than 95% of yeast cells remained viable. 
Plots for saturable binding of biotin-labelled cell wall-
extracted proteins to microplate-immobilized FN are 
shown in Fig. 1. The FN-binding capacity of the pro-
teins isolated from yeasts grown in the RPMI 1640 me-
dium was three-fold higher than that of proteins from 
YPD-cultured yeasts.
Purification of Epa6 as a major FN-binding protein of 
the C. glabrata cell wall
The whole mixture of proteins obtained by β-1,6-
glucanase treatment of C. glabrata cells cultured in the 
RPMI 1640 medium were subjected to ion-exchange 
chromatography on Resource Q column (Fig. 2). A 
competitive ligand-binding assay was applied in order to 
identify FN-binding proteins in fractions obtained during 
the protein separation procedure. The assay was based 
on the use of microplate-immobilized FN and the anal-
ysis of the competition between the proteins contained 
in the collected fractions and the whole mixture of bioti-
nylated fungal cell wall-associated proteins isolated with 
β-1,6-glucanase. Several fractions were found to exhibit 
a detectable FN-binding ability (up to 70% displacement 
in the competitive assay). These fractions were analyzed 
by SDS-PAGE, and the proteins, contained in the in-
dividual bands visualized on the gel were identified by 
LC-MS/MS (Table 1). Three fractions (elution times of 
5–7 min), representing the maximal FN-binding ability in 
the competitive assay, were found to contain epithelial 
adhesins, Epa3 and Epa6. The Epa6-containing fraction 
(eluted at 7 min) was subjected to high-performance gel 
filtration on a TSK 3000 G SW column, yielding a rea-
sonably pure protein, represented by a single although 
slightly diffused band in SDS-PAGE (Fig. 3). It was un-
equivocally confirmed by LC-MS/MS to contain Epa6 
as the only detectable component (in-gel digestion with 
trypsin, Mascot score of 312, 34% sequence coverage). 
However, the molecular mass of this protein was much 
higher than that calculated from Epa6 amino acid se-
quence (78 kDa), reflecting the heavily mannosylated 
status of Epa molecules. A slight heterogeneity of the 
Figure 1. Binding of biotinylated C. glabrata cell wall proteins to 
microplate-immobilized FN.
Before extraction with b-1,6-glucanase, the cells were cultured at 
different conditions (17 h at 30°C in the YPD medium or 72 h at 
37°C in the RPMI medium). Cell wall-extracted proteins at a con-
centration in the range of 1.5–75 μg/ml were added to immobi-
lized FN. The wells without FN, which were surface-blocked with 
3% BSA, served as a control. The non-specific binding level was 
estimated from the readings of wells without immobilized FN 
and this value was subtracted from the total binding. Data points 
represent mean values from three determinations (three wells) 
± standard deviation.
Figure 2. Separation of C. glabrata cell wall proteins by ion-ex-
change chromatography on the Resource Q column, with moni-
toring FN-binding activity.
The mixture of extracted cell wall proteins were separated as de-
scribed in the text. A representative chromatogram is presented 
as a solid line. Fractions (1 min) were collected and analyzed for 
FN-binding activity (bars) using a competitive assay. To this end, 
biotinylated cell wall proteins (final concentration of 20 μg/ml), 
mixed with chromatographic fractions (in the figure marked with 
the corresponding elution time) were added to immobilized FN. 
The statistical significance of the signals obtained against the 
signal from the control sample containing the biotinylated pro-
teins without any competitor is indicated by asterisks: *p<0.05, 
**p<0.005, ***p<0.001.
Figure 3. SDS-PAGE analysis of purified C. glabrata epithelial ad-
hesin 6.
A sample of purified Epa6 (3 μg) was analyzed on 10% gel in the 
Laemmli system under reducing conditions. After SDS-PAGE the 
protein bands were visualized by silver staining. Lane 1: molecular 
mass standard; lane 2: purified Epa6. 
Figure 4. A microplate assay for testing the interactions of puri-
fied Epa6 with fibronectin. 
The binding plot was obtained after incubation of the fluoresce-
in-labeled Epa6 (concentration range of 6–220 nM) with immo-
bilized FN. The applied experimental protocol is described under 
Methods section. The values obtained for control samples (the 
mixtures of fluorescein-labeled Epa6 with 10-fold molar excess 
of unlabeled Epa6) were subtracted from the total binding. Data 
points represent mean values from three determinations (three 
wells) ± standard deviation.
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polysaccharide moiety could account for the diffused ap-
pearance of the electrophoretic band.
Kinetic and thermodynamic characterization of the 
interaction between FN and purified C. glabrata Epa6
First, the interaction of purified Epa6 with FN was 
directly demonstrated by the semi-quantitative microplate 
ligand-binding assay (Fig. 4). Through fitting a simple 
model, i.e. one-site binding (hyperbola), to the experi-
mental data, the K0.5 parameter, which is a rough approx-
imation of the dissociation constant (KD) for the binding 
of fluorescein-labeled Epa6 to microplate-immobilized 
FN, was estimated at 7.22×10–8 M.
The quantitative SPR method was then applied to 
characterize the Epa6-FN interaction in terms of kinet-
ics and thermodynamics. To this end, FN was immobi-
lized on the CM5 chips of the BIACORE 3000 system. 
The sensograms obtained for binding of Epa6 to chip-
immobilized FN are presented in Fig. 5. A good global 
fit to the sensograms was obtained with the Langmuir 
1:1 binding model with a drifting baseline, resulting in 
the binding parameters specified in Fig. 5.
Identification of C. glabrata cell 
surface-exposed proteins
A gel-free approach, i.e. the 
“cell surface shaving”, consisting 
in short treatment of fungal cells 
with trypsin, was used to identify 
proteins that were exposed on the 
surface of yeast cells cultured un-
der different environmental condi-
tions (YPD medium vs. YPD sup-
plemented with FN). A procedure 
that had been previously applied to 
analyze C. tropicalis and C. parapsi-
losis “surfaceomes” (Karkowska-
Kuleta et al., 2015) was used in this 
study. The yeast cell integrity was 
checked in each experiment with 
the use of Trypan Blue staining, 
because the crucial requirement for 
Table 1. Mass spectrometry identification of proteins present in fractions obtained during the separation of C. glabrata cell wall pro-
teins on Resource Q column. 
After SDS-PAGE analysis, major protein bands were excised from the gel and subjected to digestion with trypsin. The peptides obtained 
were analyzed by LC-MS/MS.
Fraction (min)* Major proteins identified Protein concentration (mg/ml)
4 hypothetical protein [Candida glabrata CBS 138] similar to Saccharomyces cerevisiae putative GPI-linked cell wall mannoprotein of the Srp1p/Tip1p family 0.11
5
epithelial adhesin 3 [Candida glabrata CBS 138],
hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
enolase I (Eno1),
hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
transaldolase (Tal1),
hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
cobalamin-independent methionine synthase (Met6)
0.18
6
epithelial adhesin 3 [Candida glabrata CBS 138],
epithelial adhesin 6 [Candida glabrata CBS 138],




epithelial adhesin 6 [Candida glabrata CBS 138],
hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
triose phosphate isomerase (Tpi),
hypothetical protein [Candida glabrata CBS 138] similar to Saccharomyces cerevisiae cell wall 
mannoprotein (Cwp1),
hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
endo-beta-1,3-glucanase (Bgl2),




hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
extracellular mutant (Ecm4),
hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
triose phosphate isomerase (Tpi)
0.11
9
hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
haze protective factor (Hpf1),
hypothetical protein [Candida glabrata CBS 138] highly similar to Saccharomyces cerevisiae 
member of the FLO family of cell wall flocculation proteins (Flo10)
0.10
*1-ml fraction collected at the indicated elution time
Figure 5. SPR analysis of the interaction of Epa6 with FN.
Sensograms were obtained after injection of Epa6 (concentration of the analyte within a 
range of 5–125 nM) over a CM5 chip containing immobilized FN (level: 280 RU) at a flow 
rate of 30 μl/min. A Langmuir 1:1 binding model with a drifting baseline was well fitted to 
the sensograms, as shown by the black lines.
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Table 2. Mass spectrometry analysis of proteins identified at the cell surface of C. glabrata. 
The yeast cells were cultured at 37°C for 17 h in YPD medium or in the presence of FN in the same medium. After “cell surface shaving” 
with trypsin and additional digestion of obtained proteins for 5 hours, peptides were analyzed by LC-MS/MS. The obtained lists of peaks 
were searched against the NCBI protein database with taxonomy restriction – Fungi and SwissProt protein database with taxonomy re-












hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae enolase I (Eno1)
46.8 4.23 1052 19 50 + +
gi|50288681
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae glyceraldehyde-3-phosphate 
dehydrogenase (Tdh3)
36.0 6.19 727 17 59 + +
gi|25992752 pyruvate decarboxylase (Pdc) [Candida glabrata CBS 138] 62.0 4.57 514 12 29 + +
gi|50290317
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae alcohol dehydrogenase I (Adh1)
37.9 4.60 444 9 37 + +
gi|50291073
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae secreted glycoprotein (Ygp1)
37.8 4.24 392 10 30 + +
gi|50288201
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae stress-seventy subfamily A 
(Ssa2)
69.6 4.33 388 10 27 + +
gi|50292893
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae fructose-bisphosphate aldolase 
(Fba1)
39.5 4.75 292 6 18 + +
gi|50285959
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomy-
ces cerevisiae stress-seventy subfamily B 
(Ssb2)
66.5 5.14 280 5 13 + +
gi|50293403
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae phosphoglycerate kinase (Pgk1)
44.7 7.80 209 6 18 + +
gi|50292725
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae heat shock protein (Hsc82)
81.0 4.48 165 4 10 + +
gi|50295024
hypothetical protein [Candida glabrata 
CBS 138 ] highly similar to Saccharomyces 
cerevisiae 6-phosphogluconate dehydro-
genase (Gnd1)
53.9 6.60 121 3 10 + +
gi|50284959
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae elongation factor 2 (Ef2)
93.8 4.72 113 4 8 + +
gi|50286075
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae translation elongation factor 
(Tef1)
50.2 9.58 155 4 14 +
gi|50287821
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae elongation factor beta (Efb1)
23.0 4.05 152 3 32 +
gi|50284963 60S ribosomal protein L19 [Candida gla-brata CBS 138] 21.7 11.9 115 3 14 +
gi|3786314 translation elongation factor3 [Candida glabrata CBS 138] 116.8 5.91 109 2 2 +
gi|32563290 translation elongation factor 1-alpha, partial (Tef1) [Candida glabrata CBS 138] 50.2 270 7 20 +
gi|50293029
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae malate synthase (Mls1)
63.5 7.20 207 6 15 +
gi|50285355
hypothetical protein [Candida glabrata 
CBS 138] highly similar to Saccharomyces 
cerevisiae transaldolase (Tal1)
36.8 6.33 198 3 14 +
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the whole treatment was that cell membranes remain in-
tact, i.e., no cell lysis could occur.
This method allowed identification of 16 and 17 pro-
teins, assigned to cells grown in the YPD medium and 
the YPD medium with FN, respectively. A list of the 
identified proteins is presented in Table 2. As shown, 
12 of the identified proteins were common in yeasts 
cultured in either conditions, but some proteins were 
unique, as for example Epa6, which was found on the 
cell surface only if FN was added to the cultivation me-
dium. All abbreviated names and protein descriptions in-
cluded in this study were taken from the NCBI protein 
database and the Candida Genome Database (CGD). 
Because the genome sequence of C. glabrata is still poor-
ly described, the identified proteins were compared and 
assigned to orthologous genes/proteins from baker’s 
yeast S. cerevisiae.
DISCUSSION
Despite its close relatedness to the non-pathogen-
ic yeast S. cerevisiae, C. glabrata has become the second 
fungal pathogen in the USA and the third in Europe 
in terms of the frequency of infections caused (Mikul-
ska et al., 2012; Pfaller et al., 2012). Admittedly, issues 
concerning C. glabrata pathogenicity have been the sub-
ject of quite extensive studies in recent years; however, 
disseminated infections caused by this Candida species, 
partly due to the high drug resistance of this fungus, are 
a serious problem in the current clinical practice.
Although C. albicans and C. glabrata are considered as 
two Candida species that are most commonly distributed 
in the human population, they markedly differ in terms 
of their phylogenetic, genetic and phenotypic features 
(Polke et al., 2015). Nevertheless, the main goals during 
the invasion of host cells – nutrient acquisition and im-
mune evasion – are common for both pathogens. It is 
also interesting that the strategy to achieve these com-
mon goals is quite different for each of the Candida spe-
cies (Brunke & Hube, 2013). A critical step for the de-
velopment of fungal infection is adhesion to host cells 
and proteins through molecules exposed on the surface 
of Candida cells. It is well known that hyphal forms 
are mainly involved in this process in C. albicans. Since 
C. glabrata only exists in the yeast-like form, it had to 
develop a different strategy required for adhesion and in-
vasion of host cells.
The genome of C. glabrata contains genes that encode 
67 adhesin-like glycosylphosphatidylinositol(GPI)-an-
chored cell-wall proteins, which are classified into seven 
groups. The largest and best characterized is the Epa 
family, with Epa1, Epa6 and Epa7 being the most no-
table members. This group of proteins exhibiting diverse 
ligand-binding characteristics is involved in the interac-
tions with epithelial and endothelial cells (de Groot et al., 
2008; Diderrich et al., 2015). In terms of primary struc-
tures, Epas are similar to S. cerevisae Flo proteins and the 
members of the C. albicans Als family of typical adhesins 
that comprise three regions: a C-terminal domain with a 
GPI-anchor, a central domain with a heavily glycosylated 
Ser/Thr-rich region, and an N-terminal domain required 
for ligand recognition (Sheppard et al., 2004).
For all pathogens, the interplay between surface-
exposed proteins and human extracellular matrix pro-
teins is an essential function that facilitates development 
of infection. FN has been proven to be important for 
tissue-attachment of many prokaryotic and eukaryotic 
pathogens such as Staphylococcus spp., Streptococcus spp. 
(Schwarz-Linek et al., 2004), Treponema pallidum (Dick-
erson et al., 2012), Trypanosoma cruzi (Pinho et al., 2002) 
and Candida spp. (Nett et al., 2006; Kozik et al., 2015). 
The knowledge on the interactions of C. glabrata adhes-
ins with human FN is essentially limited to data on FN 
binding by an N-terminal fragment of Epa1, heterolo-
gously overproduced in E. coli. In the present study, we 
found a substantial body of evidence for the predomi-
nant role of Epa6 in the FN binding on the C. glabrata 
cell surface.
The proteins extracted from the cell wall of C. glabra-
ta cultured in the RPMI 1640 medium were found to 
contain Epa6 and at the same time, to exhibit high FN 
binding activity, considerably higher than that of proteins 
isolated from the YPD-cultured yeast, among which 
no Epa6 could be detected. In contrast to C. albicans, 
C. glabrata does not produce hyphal or pseudophyphal 
forms in the RPMI 1640 medium (Hoyer et al., 1995). 
This implies that these two fungal species have indepen-
dently evolved different strategies to detect the presence 
of host proteins. While the details differ, the basic prin-
ciple is the same – upon detection of the host environ-
ment, adhesins are expressed to attach to the host cells 
(Brunke & Hube, 2013).
In the fractions obtained from ion-exchange chroma-
tography with the highest FN-binding activity, two mem-
bers of the Epa family, i.e. Epa6 and Epa3, were identi-
fied by LC-MS/MS. Interestingly, in other studies, these 
particular adhesins were isolated from biofilm-forming 
cells, and a higher mRNA level for EPA6 was observed 
and correlated with increased virulence in hyper-adhesive 
clinical isolates (Gomez-Moler et al., 2015). The purifica-
tion of Epa6 was completed using high performance gel 
filtration on the TSK G 3000 SW column, which yielded 
an acceptably pure protein preparation. It was subjected 
to direct FN-binding tests to confirm the actual forma-
tion of the complex of these two proteins and to de-
termine the basic thermodynamic and kinetic parameters 
for this protein-protein interaction. The first method, i.e. 
the microplate ligand binding assay, is useful only for 
rough estimation of the dissociation constant; the sec-
ond method, SPR measurements, facilitates precise de-
termination of the kinetic constants for the complex for-
mation and dissociation, as well as the thermodynamic 
dissociation constant. Only a few similar studies based 
on application of SPR measurements and performed for 
gi|50285407
hypothetical protein [Candida glabrata 
CBS 138] similar to Saccharomyces cerevi-
siae protein with similarity to a family of 
flavodoxin-like proteins (Pst2)
29.9 5.55 169 3 24 +
gi|49617210 epithelial adhesin 6 [Candida glabrata CBS 138] 78.6 5.28 100 2 4 +
Surface-bound human proteins
FINC_HUMAN fibronectin OS=homo sapiens GN=FN1 PE=1 SV=4 266 249 14 12 +
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C. albicans have been reported so far and presented re-
ports on binding of candidal cell wall proteins with pro-
teinaceous components of the human extracellular ma-
trix (Donohue et al., 2011; Jordan et al., 2014) and the 
plasma kinin-forming system (Seweryn et al., 2015). The 
interaction between the N-terminal domain of Epa1 and 
FN was demonstrated in one report on C. glabrata, with 
an apparent KD estimated at 9.11×10–7 M (Ielasi et al., 
2014). In the present study, the dissociation constant 
for Epa6 binding to FN was determined to be lower by 
1–2 orders of magnitude (9.03×10–9 M or 7.2×10–8 M by 
SPR or the microplate ligand-binding assay, respective-
ly). These values should be classified as having moderate 
strength (Tudos & Schasfoort, 2008). Comparable values 
of KD, in a range of 3-16×10–9 M, were obtained using 
the SPR method for the interaction between FN and the 
recombinant domains of streptococcal and staphylococ-
cal adhesins (Joh et al., 1999; Allignet et al., 2012).
Our findings suggest that Epa6 is an effective adhes-
in, capable of strong interaction with extracellular matrix. 
However, it is difficult to conclude about the relative 
FN-binding strength between different Epas, because 
the only reference SPR study (Ielasi et al., 2014) was per-
formed on Epa1 N-terminal fragment heterologously ex-
pressed in bacteria and devoid of sugar elements which 
could be involved in FN binding. Our study aimed at 
purification of the natural, full length Epa6. During this 
purification procedure, Epa3 appeared in some fractions 
(Table 1) and, although not further purified, was deter-
mined by SPR to bind FN with the dissociation con-
stant in micromolar range (results not presented). One 
should also bear in mind that the specificity of ligand 
binding demonstrated by these particular Epa proteins 
might be quite different. Previous studies showed that 
most Epas, including Epa1, Epa6 and Epa7 bind to ga-
lactose-containing oligosaccharides which occur, for in-
stance, in mucin-type O-glycans (Zupancic et al., 2008; 
Maestre-Reyna et al., 2012; Diderrich et al., 2015).
The “cell surface shaving” approach has often been 
used for rapid analysis of changes occurring within 
the cell wall of live cells. The major advantage of this 
method is that, after a short incubation with trypsin, the 
cells remain viable and their membrane is not damaged 
(Olaya-Abril et al., 2014). This novel approach that al-
lows identification of a number of surface-exposed pro-
teins was successfully used for studying the cell surface 
of several bacterial species and, more recently, fungal 
opportunistic pathogens such as C. albicans (Hernáez 
et al., 2010; Vialás et al., 2012; Gil-Bona et al., 2015), 
C. parapsilosis and C. tropicalis (Karkowska-Kuleta et al., 
2015). In the present study, the comparative analysis of 
the proteinaceous components of the C. glabrata cell wall 
demonstrated some changes on the fungal cell surface 
after 17 hours of growth in the presence of human FN. 
In these experiments, FN was used at a concentration 
of 200 μg/ml, comparable to the physiological concen-
trations in human plasma (a range of 150–800 μg/ml) 
(Garat et al., 1996).
Adhesive proteins exposed on the candidal cell sur-
face might be classified into two groups. The first group 
contains classical adhesins equipped with a N-terminal 
signal peptide and exported outside the cell through 
the classical secretory pathway via the endoplasmic re-
ticulum and Golgi apparatus (Pitarch et al., 2002; Klis et 
al., 2006). The second group of proteins often termed 
as ‘atypical’, consists of mainly cytoplasmic proteins with 
evolutionary conserved enzymatic functions whose expo-
sition at the cell wall starts to be considered as a rule 
rather than an exception (Karkowska-Kuleta & Kozik, 
2014). In our work, besides the occurrence of several 
‘atypical’ proteins, the presentation of a classical adhesin, 
Epa6, on the cell surface after addition of human FN 
to the culturing medium was the most important change 
observed in the cell wall proteome. Furthermore, while 
searching the data obtained against the SwissProt data-
base with restriction to human proteins, we found FN 
to be adsorbed on the fungal cell surface. These find-
ings support the hypothesis that FN binding to C. glabra-
ta cell surfaces mainly depends on Epa6. On the other 
hand, several ‘atypical’ proteins that were identified could 
also play a role in this interaction, consistently with re-
cent suggestions that C. parapsilosis elongation factor 2, 
malate synthase, 6-phosphogluconate dehydrogenase and 
C. tropicalis enolase, fructose-bisphosphate aldolase, and 
transaldolase are involved in the interactions with human 
FN (Kozik et al., 2015).
Human FN is locally produced by fibroblasts, lym-
phocytes, macrophages, epithelial cells and vascular 
myocytes, and is present at a relatively high concentra-
tion in plasma (Alitalo et al., 1980; Magnuson et al., 1998; 
Lenselink, 2013). FN binding by C. glabrata may facilitate 
colonization of the host by preventing pathogen detach-
ment, as reported for pathogenic bacteria, Streptococcus 
pyogenes or Staphylococcus aureus, which attached to epithe-
lial cells throughout interactions with FN (Dziewanows-
ka et al., 1999; Cue et al., 2000). In contrast to active, 
hypha-mediated penetration of epithelial and endothelial 
cells by C. albicans, C. glabrata is able to enter the blood-
stream and spread relatively easily, even without damage 
to host cells, as shown in a chicken embryo model (Ja-
cobsen et al., 2011) or a mouse model (Weastwatre et al., 
2007) of candidal infection. Therefore, it was postulat-
ed that instead of active penetration, the mechanism of 
C. glabrata virulence and invasion may be based on endo-
cytosis without damaging the host cell (Li et al., 2007). It 
is also well known that C. glabrata may exist for a long 
time within macrophages without inducing inflamma-
tion; therefore, the interactions with FN might facilitate 
phagocytosis of C. glabrata cells by macrophages in order 
to enter these host cells and survive within them, as re-
ported for S. aureus (Shinji et al., 2003).
In conclusion, the present study clearly showed an in-
teraction between Epa6 and FN that might be signifi-
cant in the process of fungal adhesion to the proteins, 
cells, and tissues of the human host. As regards adhes-
ins, which target host proteins as their binding ligands, 
the knowledge in this area is still insufficient, in contrast 
to the well-described lectin-type activity of Epa proteins. 
Investigations in this field would considerably improve 
our understanding of how this pathogenic yeast can 
cause a vast range of invasive as well as superficial infec-
tions in humans.
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